John Heneberry

John Heneberry is an analytical and resourceful Brand Manager with extensive experience in marketing within the biotech industry, particularly focusing on rare diseases. Currently serving as the HCP Marketing Lead for the UPLIZNA gMG launch at Amgen, John has previously held positions at Eli Lilly and Company, where they managed diabetes payer marketing and contributed significantly to strategic contract planning. With a Bachelor of Science in International Business from Bradley University, John demonstrates exceptional learning agility and adaptability to market demands while delivering data-driven solutions.